VIVIMUSTA Trademark

Trademark Overview

On Wednesday, March 23, 2022, a trademark application was filed for VIVIMUSTA with the United States Patent and Trademark Office. The USPTO has given the VIVIMUSTA trademark a serial number of 97326086. The federal status of this trademark filing is REGISTERED as of Tuesday, September 5, 2023. This trademark is owned by Slayback Pharma Limited Liability Company. The VIVIMUSTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of cancer
vivimusta

General Information

Serial Number97326086
Word MarkVIVIMUSTA
Filing DateWednesday, March 23, 2022
Status700 - REGISTERED
Status DateTuesday, September 5, 2023
Registration Number7159025
Registration DateTuesday, September 5, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 14, 2023

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 29, 2022
Primary Code005
First Use Anywhere DateWednesday, December 7, 2022
First Use In Commerce DateWednesday, December 7, 2022

Trademark Owner History

Party NameSlayback Pharma Limited Liability Company
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressPrinceton, NJ 08540
Party NameSlayback Pharma Limited Liability Company
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressPrinceton, NJ 08540
Party NameSlayback Pharma Limited Liability Company
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPrinceton, NJ 08540

Trademark Events

Event DateEvent Description
Monday, January 9, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 26, 2022NEW APPLICATION ENTERED
Tuesday, March 29, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 5, 2023ASSIGNED TO EXAMINER
Wednesday, January 25, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 11, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 9, 2023TEAS STATEMENT OF USE RECEIVED
Friday, June 9, 2023USE AMENDMENT FILED
Monday, July 10, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 10, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 2, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 3, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, August 18, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 18, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 18, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 18, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, July 16, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 16, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 16, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 16, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 16, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 5, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 5, 2023REGISTERED-PRINCIPAL REGISTER

Related Keywords

vivimusta cancer treatment products pharmaceutical